K

Karius

203 employees

Karius sees a world where infectious disease is no longer a major threat to human health. The Karius Test uses genomics and AI to map a patient’s microbial landscape from a single blood sample to enable clinicians to make rapid treatment decisions.

Investor insights

Funding rounds participated in

$100M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2014

Funding rounds raised

Total raised

$100M

from 3 investors over 1 rounds

K

Karius raised $100M on June 2, 2024

Investors: Gilde Healthcare, Khosla Ventures and + 8 Other investors